Pharmacy Learning Network

06/11/2022

Exela Pharma Sciences is voluntarily recalling sodium bicarbonate injections due to reports of vial breakage and flying glass. https://buff.ly/3E5PbXG

03/11/2022

Check out the latest commentary from Yvette C Terrie, which focuses on addressing mental health issues.

In this commentary, Yvette C Terrie reviews the current prevalence of depression and anxiety, emphasizing the importance of routine screenings, patient education, and individualized treatment plans.

23/10/2022

Tracing reports by pharmacists resulted in cost savings by reducing leftover medications and prompting pharmaceutical interventions for patient safety. https://buff.ly/3VIdnWG

13/10/2022

A retrospective cohort study revealed a high rate of patients initiating oral oncology medications at health-system specialty pharmacies. https://buff.ly/3yCylfw

09/10/2022

A prescription antibiotic injection is under a Class II recall following the report of a strand of hair in a vial. https://buff.ly/3Mhpw0u

06/10/2022

“Naloxone services were provided in a wide range of settings and involved pharmacists with various expertise,” researchers said. https://buff.ly/3SvEke8

02/10/2022

The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee initially recommended against approving sodium phenylbutyrate/taurursodiol in March but changed their decision after reviewing new data. https://buff.ly/3y5GrNF

29/09/2022

Class I and Class II recalls have been issued for a slate of laxative products. https://buff.ly/3SFscqG

22/09/2022

Researchers investigated the effects of a smartphone-based meditation app on well-being, mindfulness, stress, and resilience among pharmacy students. https://buff.ly/3qVWXMi

18/09/2022

A Class II recall has been issued for numerous lots of acetaminophen oral solution. https://buff.ly/3S5AGa8

11/09/2022

Akorn Inc is recalling timolol maleate ophthalmic solution due to an impurity during stability testing. https://buff.ly/3d0LUhk

04/09/2022

Mark Munger, PharmD, University of Utah, reviews data demonstrating the benefits of a polypill strategy to simplify treatment and improve adherence among adults at risk for cardiovascular disease. https://buff.ly/3ADOn9r

21/08/2022

Glenmark Pharmaceuticals is voluntarily recalling a prescription diuretic and antihypertensive medication used to lower high blood pressure. https://buff.ly/3K4GkXw

14/08/2022

Teva Pharmaceuticals is voluntarily recalling a hypertension drug for failing to meet dissolution specifications. https://buff.ly/3zSNSYD

11/08/2022

“Individual stress-reduction strategies…have a limited role in reducing burnout because they do not address burnout causes and contributors,” investigators said. https://buff.ly/3bPCdlo

07/08/2022

Prescription proton pump inhibitors are under a Class II recall for failing to meet dissolution specifications. https://buff.ly/3byV447

31/07/2022

More than 50,000 syringes containing hydromorphone hydrochloride injection are under a Class II recall. https://buff.ly/3zlo1rR

24/07/2022

Numerous batches of diabetes medication are being recalled over sterility concerns. https://buff.ly/3olaw6y

17/07/2022

A prescription medication used to treat hypertension is under a Class II recall. https://buff.ly/3Pz8BqL

14/07/2022

In this commentary, Ann Latner reviews legal proceedings surrounding a months-long data breach at a Massachusetts-based pharmacy that left the personal information of 75,000 patients exposed. https://buff.ly/3uOhTXH

12/06/2022

A Class II recall has been issued for bottles of mouthwash due to a product complaint for milky blue appearance and consistency. https://buff.ly/39m7ScW

09/06/2022

A Class II recall has been issued for prescription patches used for treating patients with ADHD. https://buff.ly/3NjbDhQ

02/06/2022

New roles and opportunities for pharmacy team members were created during the COVID-19 pandemic due to the development of standardized telehealth workflows. https://buff.ly/3ahQ5ng

03/10/2021

Pfizer is voluntarily recalling all lots of a smoking cessation drug due to a nitrosamine impurity. https://buff.ly/2ZIefSx
Population Health Learning Network

02/10/2021

The FDA issued a Class II recall for a prescription anticonvulsant used with other medications to prevent seizures. https://buff.ly/3zZJepM
Population Health Learning Network

01/10/2021

A Class II recall was issued for a prescription beta blocker after a metal wire was found in a tablet. https://buff.ly/3A0kWfd
Population Health Learning Network

30/09/2021

In this week’s installment of Talking Therapeutics, we explore the pulmonary artery hypertension drug therapy landscape and highlight the findings from a seminal paper published recently. https://buff.ly/2Y3QSCM
Population Health Learning Network

In this week’s installment of Talking Therapeutics, we explore the pulmonary artery hypertension drug therapy landscape and highlight the findings from a seminal paper published recently.

23/09/2021

In the past, Talking Therapeutics has only covered virtual meetings, but in this week’s installment, Dr Jennings has his first in-person meeting recap. https://buff.ly/2XkfJRS
Population Health Learning Network

In the past, Talking Therapeutics has only covered virtual meetings, but in this week’s installment, Dr Jennings has his first in-person meeting recap.

19/09/2021

“Students held beliefs of responsibility for limiting non-vaccination,” researchers wrote, “but felt less confident in addressing concerns regarding specific vaccine components and immune system overload.” https://buff.ly/3hD6m7b
Population Health Learning Network

16/09/2021

Take the quiz and test your knowledge of dietary triggers for heartburn: https://buff.ly/3ziR4dX
Population Health Learning Network

13/09/2021

A Class II recall has been issued for 500-count bottles of a prescription blood thinner used to prevent heart problems. https://buff.ly/3DYdrsq
Population Health Learning Network

12/09/2021

The FDA issued a Class II recall of more than 19,000 bottles of a prescription muscle relaxant across three labelers. https://buff.ly/3jWPCJI
Population Health Learning Network

11/09/2021

The FDA issued a Class II recall for an over-the-counter pain medication due to deviations from Current Good Manufacturing Practice regulations. https://buff.ly/3jXJIYL
Population Health Learning Network

09/09/2021

Despite widespread consensus on the importance of addiction treatment in the ER, many hospitals fail to screen for substance use, offer medications to treat opioid use disorder, or connect patients to follow-up care. https://buff.ly/3DUrwqV
Population Health Learning Network

06/09/2021

A labeling error has prompted Eli Lilly & Company to recall a prescription medication used to help control high blood sugar in people with type 2 diabetes. https://buff.ly/3yTdCBP
Population Health Learning Network

05/09/2021

A Class I recall is active for a prescription treatment indicated for patients with high potassium, irregular heartbeat, or metabolic acidosis. https://buff.ly/3jNNZhv
Population Health Learning Network

04/09/2021

A voluntary recall initiated by KVK Tech Inc for two lots of atovaquone oral suspension has been designated Class I by the FDA. https://buff.ly/3BI0nFw

02/09/2021

“Enterprise technology—specifically cloud-based software for e-forms and content management—has made an immediate impact during one of the most terrifying periods some people have experienced in their lives,” says Tamearia Williams, MHA, practice administrator at Nature Coast Women’s Care & Family Medicine. https://buff.ly/3yybAXe
Population Health Learning Network

30/08/2021

The FDA has issued a Class II recall for more than 37,000 bottles of a prescription medication used to treat muscle spasms. https://buff.ly/3kyxapG
Population Health Learning Network

29/08/2021

The FDA is warning consumers to avoid the dietary supplement Cholestene because it contains lovastatin, the active ingredient in the FDA-approved prescription drug Mevacor. https://buff.ly/2Wv94nk
Population Health Learning Network